Dynavax Technologies Corporation

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$2.4Mgeneral payments (2019-2025)
$49Kresearch payments (2019-2025)
11,895clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $350K
2020 $324K
2021 $291K
2022 $253K
2023 $403K
2024 $442K
2025 $352K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Internal Medicine $1.3M
Family Medicine $148K
Rheumatology $131K
Hepatology $83K
Pediatrics $72K
Pediatric Infectious Diseases $69K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Teck Ling Palo Alto, CA Internal Medicine $1,125,008.67
Carol Brosgart Berkeley, CA $143,239.52
Sean Bennett Charlottesville, VA $134,475.00
Dennis Carson La Jolla, CA Rheumatology $130,102.44
Arun Jesudian New York, NY Hepatology $74,272.09
Peter Patriarca Bethesda, MD $63,300.00
Robert Perrillo Dallas, TX Gastroenterology (Internal Medicine) $29,142.01
Syeda Amna Husain Marlboro, NJ Pediatrics $25,500.00
David Weber Chapel Hill, NC Pediatric Infectious Diseases $20,666.52
Gregory Poland Rochester, MN Internal Medicine $20,125.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.